By Joye Bramble PhD, Exton Site Head and Vice President, Biopharmaceutical Development at Eisai US Our scientific understanding of cancer has undergone a significant transformation over the last...

Ronak Patel Adelle Berezinsky Dr. Vivek Subbiah, M.D. Associate Director, Scientific Engagement and Digital Communications Eisai Director, Medical Information and Education Eisai Executive Medical...

Learn from oncology experts Eleonora Teplinsky, MD, a breast and gynecologic medical oncologist at Valley Health System, Melissa Wilson, MD, PhD, a medical oncologist at St. Luke’s University...

As we recognize National Women’s Health Week, I consider how far collectively academia, the clinical community and industry have come in advancing treatments for women’s cancers. Work to...

The European Society for Medical Oncology (ESMO) Virtual Congress 2020 took place from September 19-21. The theme of this year’s conference was “Bringing Innovation to Cancer Care”. Our...

By Shrividya Iyer, PhD, Oncology Lead, US HEOR & RWE, and Sanjay Gupta, PhD, MBA, Department Head, Health Economics, Outcomes Research and Real World Evidence Over the past decade, the term...

By Caroline Ojaimi, Director, US Medical Affairs, Strategy and Operations In late 2019, before the coronavirus pandemic, our Medical Affairs team at Eisai realigned our priorities. We agreed that...

By Luca Dezzani, Vice President, U.S. Medical Affairs, Oncology Business Group In the wake of COVID-19, we were forced into a virtual world that, in many ways, we weren’t entirely ready for. We...

By Asya Kogan, Executive Director, Field Medical, Oncology, Eisai For a medical science liaison (MSL), being “in the field” isn’t what it used to be. Over the years, quite a lot has...

By Tracey Cannova, Associate Medical Director, US Oncology Medical AffairsBy Tracey Cannova, Associate Medical Director, US Oncology Medical Affairs Working in medical affairs is exciting and...